Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹278 Cr
up ₹34.7 Cr vs Dec 2019
- Stocks held
- 23
- up 1 vs Dec 2019
- Top 10 weight
- 61.0%
- of the portfolio in its ten largest
- Cash & debt
- 3.2%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 3
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2020 it disclosed 23 stocks worth ₹278 Cr, up ₹34.7 Cr from Dec 2019. Its largest positions were Dr. Reddy's Laboratories Limited (9.9%), IPCA Laboratories Limited (9.3%), Divi's Laboratories Limited (7.3%); the ten largest together made up 61.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 65.6% of its equity. Cash and debt stood at 3.2%. Compared with Dec 2019 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
46%
Holds more cash than 46% of peers
What these mean: concentration · cash
Holdings in January 2020
Download CSVEvery line the fund disclosed, with the change against Dec 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Dr. Reddy's Laboratories Limited | 9.87% | down 0.54 pts | ₹27.5 Cr | up ₹2.1 Cr | Added |
| IPCA Laboratories Limited | 9.32% | down 0.31 pts | ₹25.9 Cr | up ₹2.5 Cr | Added |
| Divi's Laboratories Limited | 7.31% | up 0.51 pts | ₹20.3 Cr | up ₹3.8 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 7.07% | up 0.13 pts | ₹19.7 Cr | up ₹2.8 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.89% | up 0.05 pts | ₹16.4 Cr | up ₹2.2 Cr | Added |
| Indoco Remedies Limited | 5.43% | up 0.07 pts | ₹15.1 Cr | up ₹2 Cr | Added |
| Sun Pharmaceutical Industries Limited | 5.38% | down 0.74 pts | ₹15 Cr | up ₹6 L | Held |
| Jubilant Pharmova Limited | 3.94% | down 0.21 pts | ₹11 Cr | up ₹86 L | Added |
| Max India Limited | 3.56% | down 0.29 pts | ₹9.9 Cr | up ₹52 L | Added |
| Alembic Pharmaceuticals Limited | 3.25% | down 0.11 pts | ₹9 Cr | up ₹85 L | Added |
| Syngene International Limited | 3.24% | down 0.53 pts | ₹9 Cr | down ₹17 L | Trimmed |
| Cash, TREPS & receivables | 3.20% | up 0.57 pts | ₹8.9 Cr | up ₹2.5 Cr | Added |
| Torrent Pharmaceuticals Limited | 3.17% | down 0.30 pts | ₹8.8 Cr | up ₹37 L | Added |
| Procter & Gamble Health Limited | 3.15% | down 0.40 pts | ₹8.8 Cr | up ₹11 L | Added |
| Abiomed Inc | 3.12% | down 0.06 pts | ₹8.7 Cr | up ₹93 L | Added |
| Narayana Hrudayalaya Limited | 3.07% | up 3.07 pts | ₹8.5 Cr | up ₹8.5 Cr | New |
| Abbott Laboratories | 3.05% | up 0.23 pts | ₹8.5 Cr | up ₹1.6 Cr | Added |
| Alkem Laboratories Limited | 2.98% | up 0.12 pts | ₹8.3 Cr | up ₹1.3 Cr | Added |
| Abbott India Limited | 2.84% | down 0.55 pts | ₹7.9 Cr | down ₹36 L | Trimmed |
| Ajanta Pharma Limited | 2.64% | down 0.01 pts | ₹7.3 Cr | up ₹89 L | Added |
| Aarti Drugs Limited | 2.63% | down 0.20 pts | ₹7.3 Cr | up ₹42 L | Added |
| Unichem Laboratories Limited | 2.57% | down 0.28 pts | ₹7.2 Cr | up ₹20 L | Added |
| Dr. Lal Path Labs Limited | 2.01% | up 0.07 pts | ₹5.6 Cr | up ₹87 L | Added |
| ICICI Lombard General Insurance Company Limited | 1.31% | down 0.26 pts | ₹3.6 Cr | down ₹19 L | Trimmed |
What changed, Dec 2019 to Jan 2020
New New positions (1)
- Narayana Hrudayalaya Limited3.1% · ₹8.5 Cr
Exited Exited (0)
None.
Added Biggest additions
- Divi's Laboratories Limitedup ₹3.8 Cr (+0.51% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹2.8 Cr (+0.13% pts)
- IPCA Laboratories Limitedup ₹2.5 Cr (−0.31% pts)
- Apollo Hospitals Enterprise Limitedup ₹2.2 Cr (+0.05% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2019, the weight rose most in Healthcare Services (+2.5 pts), and fell most in Pharmaceuticals & Biotechnology (−2.3 pts) and Insurance (−0.3 pts).
- Healthcare Services19.1% → 21.6%+2.5 pts
- Pharmaceuticals & Biotechnology67.9% → 65.6%−2.3 pts
- Insurance1.6% → 1.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2019 | Jul 2019 | Oct 2019 | Dec 2019 | Jan 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.9% | 69.4% | 68.5% | 67.9% | 65.6% |
| Healthcare Services | 14.7% | 16.7% | 18.9% | 19.1% | 21.6% |
| Pharmaceuticals | 10.0% | 11.7% | 11.0% | 11.3% | 11.4% |
| Insurance | 2.4% | 2.2% | 1.6% | 1.6% | 1.4% |
Allocation in Jan 2020change vs Dec 2019
- Pharmaceuticals & Biotechnology (13)65.6%▼ 2.3 pts
- Healthcare Services (6)21.6%▲ 2.5 pts
- Pharmaceuticals (3)11.4%▲ 0.1 pts
- Insurance (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2020
3.2%
▲ 0.6 pts vs Dec 2019
- Cash alone
- 3.2%
- cash and net receivables
- A year earlier
- 19.5%
- Jan 2019 · now ▼ 16.3 pts
- Last 12 months
- 1.7% – 13.1%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.